Recent 8-K filings for DXPE

• May 7, 2026, 7:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01 ◈ Earnings Releases

  DXP Q1 sales $521.7M (+9.5% YoY), EPS $1.22, Adjusted EBITDA $57.8M

  Sales increased 9.5% year-over-year to $521.7 million for Q1 2026.

• February 26, 2026, 6:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  DXP Enterprises reports fiscal 2025 sales $2B, up 11.9%; net income $88.7M, EPS $5.37

  Fiscal 2025 sales $2.0B, up 11.9% YoY; GAAP diluted EPS $5.37.

• December 22, 2025, 6:59 PM ET debt materiality 0.70 positive item 2.03item 1.01item 8.01item 9.01 ◈ Debt Financings

  DXP refinances debt, adds $205M incremental term loan, totals $848M at SOFR+3.25%

  Entered Term Loan Amendment on Dec 16, 2025; $205M incremental term loan brings total borrowings to $848M.

• November 6, 2025, 6:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01

  DXP Q3 2025 sales $513.7M (+8.6% YoY); GAAP EPS $1.31; three acquisitions closed

  Revenue $513.7M, up 8.6% YoY; GAAP diluted EPS $1.31; Adjusted EBITDA $56.5M.

• August 7, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  DXP reports Q2 FY25 sales of $498.7M, up 11.9% YoY; GAAP EPS $1.43

  Sales $498.7M, up 4.6% sequential and 11.9% year-over-year; GAAP diluted EPS $1.43.

• July 9, 2025, 7:59 PM ET debt materiality 0.65 positive item 2.03item 1.01item 8.01item 9.01 ◈ Debt Financings

  DXP Enterprises expands ABL revolver by $50M to $185M to support acquisitions

  ABL facility increased from $135M to $185M effective July 1, 2025.

• June 20, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.07

  DXP shareholders re-elect all six directors, approve compensation, ratify auditor

  All six director nominees re-elected: David R. Little, Kent Yee, Joseph R. Mannes, Timothy P. Halter, David Patton, Karen Hoffman.

• May 8, 2025, 7:59 PM ET earnings materiality 0.75 positive item 2.02item 9.01

  DXP Q1 2025 sales $476.6M (+15.5% YoY); GAAP EPS $1.25; acquires Arroyo

  Sales $476.6M, up 15.5% YoY; GAAP diluted EPS $1.25.

• March 7, 2025, 6:59 PM ET earnings materiality 0.80 positive item 2.02item 9.01

  DXP Enterprises reports FY2024 sales $1.8B, up 7.4%; diluted EPS $4.22

  Fiscal 2024 sales $1.8B, up 7.4% YoY; net income $70.5M vs $68.8M in FY2023.

• November 7, 2024, 6:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  DXP Q3 sales $472.9M (+12.8% YoY), GAAP EPS $1.27, Adj EBITDA $52.4M

  Sales of $472.9 million, up 12.8% year-over-year and 6.1% sequentially.

• October 9, 2024, 7:59 PM ET debt materiality 0.70 positive item 2.03item 1.01item 8.01item 9.01

  DXP adds $105M term loan, cuts margin 100 bps, total borrowings $649.5M

  Incremental $105M term loan brings total outstanding to $649.5M; matures Oct 13, 2030.

• August 28, 2024, 7:59 PM ET other material materiality 0.55 positive item 8.01item 9.01

  DXP Enterprises announces $85M share repurchase program, replacing completed $85M program

  Board authorizes repurchase of up to $85M or 2.5M shares over 24 months in open-market or private transactions.

• August 8, 2024, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  DXP Enterprises Q2 sales up 4.1% YoY to $445.6M; diluted EPS $1.00

  GAAP diluted EPS of $1.00; Adjusted EBITDA of $48.2M.

• June 18, 2024, 7:59 PM ET other material materiality 0.15 neutral item 5.07

  DXP shareholders elect all six director nominees, approve say-on-pay and auditor ratification

  All six director nominees re-elected with support ranging from 79.1% (Karen Hoffman) to 98.3% (David Little).

• May 9, 2024, 7:59 PM ET earnings materiality 0.70 positive item 2.02item 9.01 ◈ Earnings Releases

  DXP Enterprises Q1 2024: sales $412.6M, GAAP EPS $0.67, non-GAAP EPS $0.74

  Sales of $412.6M; GAAP diluted EPS $0.67; non-GAAP diluted EPS $0.74.

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.80 · Median 0.70 · Most common event earnings

13 positive 0 negative 2 neutral

source · DXPE on sec.gov